demonstrated that CD36-mediated ferroptosis could impede the effector function of intratumoral CD8+ T cells and inhibit their antitumor effects in melanoma and multiple myeloma, and suppressing ferroptosis in CD8+ T cells primarily restored their antitumor activity, with more significant effects in combination with ICIs (20). The gene discussed is CD8A; the disease is plasma cell myeloma.